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Introduction
In Western countries, prostate cancer (PCa) is the most 
common male cancer (Australian Government, 2013; 
Canadian Cancer Society, 2013; Centers for Disease 
Control and Prevention, 2013). Affecting 1 in 7 men, the 
incidence of PCa is increasing with an aging male popu-
lation and improved screening (Canadian Cancer Society, 
2013). Men are also living longer with PCa, and the death 
rate continues to be low amid increases in the number of 
men being diagnosed (Australian Government, 2013; 
Canadian Cancer Society, 2011; Centers for Disease 
Control and Prevention, 2013). In the absence of a known 
modifiable cause, for many men, PCa will be a chronic 
illness (Canadian Cancer Society, 2013; Jemal et al., 
2009; Remzi, Waldert, & Djavan, 2004). Diverse mor-
bidities can accompany PCa and its treatments, including 
erectile dysfunction and urinary incontinence; psychoso-
cial supports are thus integral to the well-being of men 
who have PCa and their families (Arrington, 2010; 
Chapple & Ziebland, 2002; Charmaz, 1995; Fergus, 
Gray, & Fitch, 2002a, 2002b; Gannon, Guerro-Blanco, 
Patel, & Abel, 2010; Meuleman & Mulders, 2003; Navon 
& Morag, 2003a, 2003b; Oliffe, 2005, 2006; Wall & 
Kristjanson, 2005). Among an array of psychosocial 
oncology options, prostate cancer support groups 
(PCSGs) have prevailed as important community-based 
resources in Canada and other Western countries 
(Arrington, 2010; Arrington, Grant, & Vanderford, 2010; 
Gray et al., 1999; Gray, Fitch, Davis, & Phillips, 1996; 
Gray, Fitch, Davis, & Phillips, 1997; Gray, Fitch, Phillips, 
Labrecque, & Fergus, 2000b; Matsunaga & Gotay, 2005; 
Steginga et al., 2001; Zanchetta, Cognet, Xenocostas, 
Aoki, & Talbot, 2007). However, the sustainability of 
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Abstract
To understand prostate cancer (PCa) specialists’ views about prostate cancer support groups (PCSGs), a volunteer 
sample of Canada-based PCa specialists (n = 150), including urologists (n = 100), radiation oncologists (n = 40), 
and medical oncologists (n = 10) were surveyed. The 56-item questionnaire used in this study included six sets of 
attitudinal items to measure prostate cancer specialists’ beliefs about positive and negative influences of PCSGs, 
reasons for attending PCSGs, the attributes of effective PCSGs, and the value of face-to-face and web-based PCSGs. In 
addition, an open-ended question was included to invite additional input from participants. Results showed that PCSGs 
were positively valued, particularly for information sharing, education and psychosocial support. Inclusivity, privacy, 
and accessibility were identified as potential barriers, and recommendations were made for better marketing PCSGs 
to increase engagement. Findings suggest prostate cancer specialists highly valued the role and potential benefits of 
face-to-face PCSGs. Information provision and an educational role were perceived as key benefits. Some concerns 
were expressed about the ability of web-based PCSGs to effectively engage and educate men who experience prostate 
cancer.
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volunteer-run PCSGs have been challenged by recruit-
ment and leadership succession issues (Oliffe et al., 
2008). Relatedly, PCSGs diverse connections to cancer 
agencies and health care providers can influence group 
viability. For example, health care providers who share 
information at PCSGs and/or refer patients to group 
meetings can advance the effectiveness and reach of 
PCSGs. While PCa specialists are an important health 
care provider subgroup, well positioned to link with 
PCSGs in a variety of ways the perceptions and practices 
of PCa specialists regarding PCSGs are poorly under-
stood. In addressing the research question, what are 
Canada-based PCa specialists’ views about PCSGs? This 
study and article offers some empirical insights to address 
this knowledge gap and thoughtfully consider avenues 
for maximizing the potential of PCSGs.
Background
In contrast to the diversity in clinical psychosocial PCa 
programs, PCSGs are somewhat uniform in their provi-
sion of support, with both face-to-face and virtual groups 
focusing on (1) educational presentations from medical 
experts and/or (2) group discussions about treatment 
options, disease management, and/or health promotion 
(Oliffe, Gerbrandt, Bottorff, & Hislop, 2010; Seale, 
Ziebland, & Charteris-Black, 2006; Thaxton, Emshoff, & 
Guessous, 2005). Research indicates that men attend 
PCSGs to learn about their disease and treatment options 
and side effect management from other men who have 
direct experience, as well as from an array of health care 
providers (Arrington et al., 2010; Gray et al., 1997; 
Klemm, Hurst, Dearholt, & Trone, 1999; Manne, 2002; 
Oliffe et al., 2010; Seale et al., 2006; Smith, Crane, Byers, 
& Nelson-Marten, 2002; Thaxton, Emshoff, & Guessous, 
2005). Women partners also attend PCSGs (Bottorff et 
al., 2008; Thaxton et al. 2005) and the group leaders can 
comprise health care providers and survivors. Compared 
with information provision, some have argued that 
PCSGs are less equipped to support men’s emotional dis-
tress (Arrington et al., 2010; Coreil & Behal, 1999; Weber 
& Sherwill-Navarro, 2005). Although experiencing sig-
nificant psychosocial concerns in relation to being diag-
nosed, it has also been reported that men typically adopt 
an “instrumental” coping style oriented to action and 
focus on “functionality” more than “feelings” in the con-
text of in-person and online PCSGs (Klemm et al., 2003; 
Oliffe et al., 2010, Seale et al., 2006). So while many men 
do share ordinarily private illness experiences at PCSGs 
(Oliffe et al., 2010), research indicates that emotional 
supports are secondary motivations for attendance 
(Thaxton et al. 2005; Voerman et al., 2007).
The vast majority of PCSG research has focussed on 
the benefits and barriers to attending group meetings. 
Previous work detailing benefits includes an interview 
study of 12 men—most of whom had leadership roles in 
PCSGs located at Winnipeg, Toronto, and Ottawa—
reporting that men derived a sense of meaning and pur-
pose through attending PCSGs (Gray et al., 1997). 
Similarly, a survey of men who attended a professionally 
led, Montreal-based PCSG reported that the sharing of 
PCa experiences gave men reassurance, helped alleviate 
anxiety, and provided a positive outlook and perception 
of being involved in their treatment (Gregoire, 
Kalogeropoulos, & Corcos, 1997). The benefits described 
in these studies are confirmed elsewhere wherein PCSGs 
have been reported as useful in mitigating the psychoso-
cial aspects of cancer by conveying information, empow-
ering men with PCa, enhancing and facilitating 
psychosocial adjustment, and helping men and their part-
ners cope with life after a diagnosis and treatment of can-
cer (Arrington, 2003; Arrington et al., 2010; Cordova et 
al., 2003; Gray et al., 1997; Katz et al., 2002; Manne, 
2002; Steginga et al., 2001; Voerman et al., 2007; Walker, 
2005; Weber et al., 2004; Zhang et al., 2008).
In terms of barriers to attending PCSGs, an interview 
study with 34 Canadian men and their partners led Gray, 
Fitch, Phillips, Labrecque, and Fergus (2000a) to suggest 
PCSGs were poorly attended because men typically avoid 
disclosure due to low perceived need for support, fear of 
stigmatization, the need to minimize the threat of illness 
to aid coping, practical necessities in the work place, and 
the desire to avoid burdening others. Related to this, 
US-based and Australian-based men’s misperceptions 
that PCSG meetings were geared toward emotional sup-
port of the terminally ill (Krizek, Roberts, Ragan, Ferrara, 
& Lord, 1999; Walker, 2005) and a sense of shame and 
embarrassment about sharing personal information 
(Smith et al., 2002; Weber, Roberts, & McDougall, 2000) 
were identified as barriers to attending support groups.
There is also evidence that health care providers 
strongly influence men’s interest in attending a “support” 
group. For example, health care providers’ lack of aware-
ness of PCSGs can be a barrier (Smith et al., 2002). A 
survey questionnaire study of 1,224 attendees at 
Australian-based PCSGs confirmed that the clinician’s 
level of endorsement for men’s participation in PCSGs 
strongly influenced them to attend (Steginga, Pinnock, 
Gardiner, Dunn, & Gardiner, 2005). This finding led 
researchers to conclude that clinicians are integral to the 
development and implementation of support services for 
men with PCa (Steginga et al., 2005). A subsequent study 
of 36 clinicians (27 urologists and 9 radiation oncolo-
gists) by Steginga et al. (2007) identified that participants 
were reluctant to refer patients to PCSGs, fearing that 
biased viewpoints and misinformation within the groups 
might contribute to men’s uncertainty and decisional 
regret.
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In summary, there is consensus that PCSGs provide 
important resources to men and their families; however, 
group sustainability can be challenged by failing to attract 
new attendees, which in turn reduces the capacity for 
group leadership succession planning (Oliffe et al., 2008). 
Related to this it seems that men’s resistance to attending 
PCSGs might stem from concerns about how the groups 
operate and the legitimacy of the resources that they pro-
vide. In this regard, PCa specialists are well positioned to 
inform men about the availability of PCSGs. While PCa 
specialists’ reliability for reporting what may or may not 
motivate PCa patients to attend a support group is debat-
able, their collective views about PCSGs provide impor-
tant insights to thoughtfully consider avenues for 
maximizing the potential of PCSGs.
Subjects and Method
This study was approved by the University of British 
Columbia’s Behavioural Research Ethics Board 
Committee. The survey instrument to solicit the PCa spe-
cialists’ views was developed as a web-survey composed 
of a 56-item questionnaire based on Steginga et al.’s 
(2007) study tool. The survey items were first developed 
from in-depth expert stakeholder interviews with 36 cli-
nicians (27 urologists and 9 radiation oncologists) who 
had provided care to men with PCa for a mean of 16 
years. To confirm item relevance in an iterative approach 
a follow-up paper-based survey applying a 5-point Likert-
type scale was completed by 30 of these participants from 
which key themes were identified. For the current study 
incorporated were five demographic questions and six 
sets of attitudinal items to measure beliefs about: positive 
influences of PCSGs, negative influences of PCSGs, rea-
sons for attending PCSGs, the attributes of effective 
PCSGs, and the value of face-to-face and web-based 
PCSGs. Each set of attitudinal items included five to nine 
questions that were rated by respondents using a 5-point 
Likert-type scale (where 1 = strongly disagree and 5 = 
strongly agree). An open-ended question to provide addi-
tional information was also included. Reliabilities for the 
current study ranged from .72 to .94. This instrument is 
available on request.
In all, 150 PCa specialist respondents were recruited 
via existing professional contacts and the Canadian 
Urological Association. There was a nominal honorarium 
of a $50 gift card of their choice, which was mailed to 
respondents on receipt of the completed survey. 
Descriptive statistics are reported. Median scores are 
reported for ordinal Likert data. Responses to the open-
ended questions were coded and content analyses per-
formed to inductively derive broad descriptive categories. 
Respondents included 100 urologists, 40 radiation oncol-
ogists, and 10 medical oncologists. Table 1 presents 
descriptive data on the demographic and professional 
characteristics of the sample. Of 150 respondents, 82.7% 
(n = 124) were male and the majority of respondents 
practiced in British Columbia (38.0%) and Ontario 
(33.3%). Respondents worked in a variety of settings, 
including hospitals and/or cancer centers. They ranged in 
age from 26 to 86 years (mean age = 44.7 years) and had 
an average of 13.8 years’ experience working with PCa 
patients. The majority (62.0%) reported formally present-
ing information at PCSGs, and 78% indicated that they 
had referred patients to PCSGs.
Results
Features of PCSGs That Positively Influence 
Men’s Adjustment to PCa
Respondents provided ratings of seven features of PCSGs 
that were potentially positive influences on men’s adjust-
ment to PCa (Figure 1). Ratings of these features were 
uniformly high (median of five). All seven characteristics 
(i.e., community support, reassurance, social identity, 
sharing experiences, emotional support, and providing 
information) were identified as important benefits. While 
friendship was rated the lowest of the items, sharing 
experiences and emotional support were highlighted as 
the strongest factors positively influencing men’s adjust-
ment to PCa.
Features of PCSGs That Negatively Influence 
Men’s Adjustment to PCa
Specialists rated nine items related to possible nega-
tive influences of PCSGs including, meeting with 
dominant members who push their own views, dissem-
ination of inaccurate information, hearing negative 
experiences, creating conflict over treatment deci-
sions, promoting a specific clinician, creating confu-
sion, supplying irrelevant information, causing 
confrontation, and promoting a single therapy (Figure 2). 
PCSG meetings with dominant members, dissemina-
tion of inaccurate information, and hearing negative 
experiences were identified as the three leading nega-
tive influences of PCSGs affecting men’s adjustment 
to PCa. The median response for the other six items 
was 3 (neutral) with no specific negative factors being 
identified as particularly influential. In addition, some 
negative influences were apparent in the open-ended 
responses discussed below.
Reasons for Attending PCSGs
The items most strongly endorsed by PCa specialists as 
the reasons that men attended PCSGs were to discuss PCa 
treatments and to gain information (median of 5; see 
Figure 3).
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Reasons for Not Attending PCSGs
Perceived reasons for not attending PCSGs were assessed 
with seven items. Privacy issues was the most clearly 
endorsed reason for not attending PCSGs (median of 5), 
followed by ignorance of PCSGs (Figure 4). Items includ-
ing “no need,” “having enough information,” and “a 
desire to move past the PCa experience,” were also highly 
endorsed by PCa specialists (median of 4) as reasons why 
some men might prefer not to attend PCSGs.
Characteristics of Effective PCSGs
Respondents rated items to assess their views on the char-
acteristics of effective face-to-face PCSGs. Avoiding bias 
by not promoting one view of treatment, a range of differ-
ent health care providers’ input, being patient-driven, and 
diversity of therapies discussed were the most highly 
endorsed characteristics of effective PCSGs (median rat-
ing of 5; Figure 5). Supported by other health care pro-
viders, having a trained facilitator, and support from 
health organizations were also generally agreed as keys to 
success (median rating of five).
Characteristics of Effective Web-Based PCSGs
Provision of summarized PCa information, the use of 
multimedia evidence-based health care provider presen-
tations, and the facilitation of camaraderie were identi-
fied as the most essential features of effective web-based 
PCSGs (Figure 6). The findings suggest that specialists 
are most concerned with the accuracy and interactive 
capacity of the information made available online.
Additional Commentary
Thirty-four respondents shared additional insights via 
written comments. Table 2 presents the results from the 
content analysis of the open-text comments. In summary, 
the main cautions related to online PCSGs and prostate 
specific antigen advocacy. Online PCSGs were predicted 
to encounter similar shortcomings, and they were sug-
gested to augment rather than replace face-to-face meet-
ings for a variety of reasons including older men’s 
reduced access to online resources. In terms of endorse-
ments and suggestions for promoting the work of PCSGs, 
respondents offered a range of ideas, including messag-
ing individual clinicians about the groups and supplying 
brochures to clinics that patients could take with them.
Discussion
The results from the current study provide important 
insights to PCa specialists’ awareness of the benefits of 
PCSGs for men with regards to emotional support under-
pinned by the sharing of personal experience. Men are 
typically underrepresented as seekers of psychological 
support after cancer (Steginga et al., 2008) and a recent 
U.S. study indicated that PCa patients are approximately 
Table 1. Demographic & Professional Characteristics of the 
Study Sample.
Demographic characteristic n (%)
Age in years (mean = 44.7, range = 26-86)
 20-30 13 (8.7)
 31-40 51 (34.0)
 41-50 39 (26.0)
 51-60 31 (20.6)
 60+ 15 (10.0)
 Unspecified 1 (0.7)
Gender
 Male 124 (82.7)
 Female 26 (17.3)
Practice location (province)
 Alberta 16 (10.7)
 British Columbia 57 (38.0)
 New Brunswick 3 (2.0)
 Manitoba 5 (3.3)
 Newfoundland 1 (0.7)
 Nova Scotia 3 (2.0)
 Ontario 50 (33.3)
 Quebec 11 (7.3)
 Saskatchewan 4 (2.7)
Years working with prostate cancer patients
 1-10 73 (48.7)
 11-20 43 (28.7)
 21-30 23 (15.3)
 31+ 11 (7.3)
Linkages to PCSGs
 Presenter at group 93 (62.0)
 Referred patients to group 117 (78.0)
 Group member 7 (4.7)
 Group leader 1 (0.7)
 No linkages 5 (3.3)
 Other (n = 5)
  Web-based PCSG leader  
  Receives weekly newsletter from 
local group
 
  Spoken to patients about PCSGs  
  PCSGs advisor  
  Academic writing on prostate 
cancer
 
Types of practice (respondents could endorse more than one 
practice type)
 Hospital 90 (60.0)
 Cancer centre 60 (40.0)
 Private 48 (32.0)
Note. Percentages may not total 100 because of rounding. PSCGs = 
prostate cancer support groups.
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30% less likely than breast cancer patients to have dis-
cussed emotional and social concerns with their health 
care provider (Forsythe et al., 2013). In light of these 
findings it may be that although PCa specialists appear to 
understand and endorse the benefits of face-to-face 
PCSGs, emotional and social care, and therefore raising 
patient awareness about support groups is not necessarily 
a priority. That said, given that many men with PCa report 
unmet needs for support with regards to fears about the 
cancer returning or spreading and worry about “signifi-
cant” others (Lintz et al., 2003; Smith et al., 2007; 
Steginga et al., 2001), PCSGs present as a valuable but 
potentially underused support program.
Contrasted within the current study findings that shar-
ing experiences and emotional support were the most 
positive influences of PCSGs on men’s adjustment, PCa 
specialists rated information as men’s primary motivation 
for attending groups. Interestingly, the key reasons 
endorsed as potentially negative effects of support groups 
including online groups, centered on misinformation. 
This may reflect the uncertainty that persists about the 
optimal treatment approach for PCa, the expanding array 
of treatment options and regimes, and from this, clini-
cians concerns about supporting men’s decision making 
in the clinical encounter. Men with PCa often report high 
decisional conflict that for some persists over time 
(Steginga, Occhipinti, Gardiner, Heathcote, & Yaxley, 
2004), and men do report others cancer experiences, both 
positive and negative, as influencing their treatment 
choices (Steginga et al., 2002). Hence, this is a highly 
salient clinical issue for specialists in these men’s care.
There was less agreement on the value of PCSG in 
terms of social interaction and helping other men with 
PCa, suggesting that some PCa specialists believe the 
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group format of PCSGs may be unappealing to men and 
dissuade them from attending. These views may also sug-
gest that PCa specialists do not anticipate men to be long-
term attendees.
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Figure 3. Reasons why men choose to attend a prostate cancer support group.
1
1
4
2
1
2
10
1
2
12
24
21
12
10
7
41
20
9
32
39
54
36
45
28
65
61
91
84
79
60
86
77
88
29
58
48
21
7
11
14
17
25
5
10
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Privacy
No need
Denial
Language Difficules
Have Enough Info
Want to Move on
Ignorance of PCSG
Indebtedness
Weakness
Strongly disagree Disagree Neutral Agree Strongly agree
Figure 4. Reasons why men choose not to attend a prostate cancer support group.
Oliffe et al. 169
2
2
4
6
11
11
4
21
22
3
2
69
60
34
48
63
32
34
61
68
82
60
51
91
80
7
9
30
17
8
24
34
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Web 2.0 Intereacvity
Separate area for men
EBP Mulmedia content
Login not required
Led by PCa survivor
Summarized PCa info 
Facilitates Camaraderie
Strongly disagree Disagree Neutral Agree Strongly agree
Figure 6. Key factors for the effectiveness of a web-based prostate cancer support group.
Table 2. Main Endorsements and Cautions From Open-Ended Question.
Endorsements Cautions
•• They have gradually transitioned over the years from 
consisting of those with bad experiences looking for 
support to those made up of men truly interested in 
helping their peers.
•• They are important and should be available in all academic 
centers across Canada.
•• Support groups are vital to the overall treatment of any 
disease particularly malignancies such as prostate cancer.
•• Support groups of huge value to patients trying to make 
initial decision.
•• I think it is worth making patients aware of so they can 
choose to be involved if it’s right for them. I think it is 
important that these types of things remain patient driven.
•• Need more awareness of such programs.
•• Web-based solutions should link prostate cancer support 
groups across regions, to integrate smaller ones into bigger 
ones for enhanced support.
•• A brochure that could be given out in clinic about support 
groups would be helpful—they could take home and have 
time to think about it and see what it’s about and reach 
out on their own rather than getting a yes or no in clinic if 
they are interested.
•• Please send individual practitioners more information 
about support groups.
•• Prostate cancer support groups could also be used as a 
forum for discussing other health problems, especially 
cardiovascular diseases, since men with prostate cancer 
are more likely to die from it than from prostate cancer.
•• I’ve enjoyed participating educating and presenting at 
prostate cancer group.
•• Generally great people, but are really dependent on the skills 
of its members and limited by resources and contacts. I have 
had concerns in the past about messaging going out about 
prostate cancer screening from the support groups locally.
•• A group with an open approach is best. Not focusing on any 
one treatment, or area. Avoid advocacy.
•• I think face-to-face contact is important with web-based 
contact as an adjunct.
•• Web based and groups are for different populations, that 
is, younger and older patients they also serve different 
purposes the first for objective information and the second 
for emotional support.
•• Anonymity of web-based forms are a two edged sword. 
They do broaden the reach but allow for easier hijacking 
by individuals/groups with agendas and biases (i.e., logging 
on of an individual with more than one identity providing a 
discussion which is really a directing monologue). In the web, 
it is also harder to identify geographic variances (could be 
both good and bad).
•• I personally feel that web-based support groups would be 
difficult for our elderly patients (confusing). I favor group 
meetings.
•• I have concerns about the quality and accessibility of web 2.0 
options for support groups for many of our more elderly 
patients—I think they do however have potential for a 
strong role with our younger patients, families, and selected 
older patient populations. My fear having presented to these 
groups is that the range of disease is quite broad.
•• In our area, the average participant at our support group is 
over 65, I am not sure they would participate to a web-based 
support group.
•• I would think the benefits and goals of a web-based group 
may be different from an in-person group, and I’d have more 
concern about the web-based approach, regarding risks of 
misinformation, miscommunication, hostility from anonymous 
contributors, potential risks to confidentiality, etc. I wouldn’t 
personally feel that a web-based utility would be the optimal 
method for support group conduct or purposes.
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The overarching endorsement of specialists for face-
to-face PCSGs suggest some shifts to Steginga et al. 
(2007) findings which highlighted specialists’ concerns 
about the potential for misinformation. Such subtle 
changes are likely influenced by an array of factors 
including specialists’ direct exposure to PCSGs, increased 
clinical emphasis on shared treatment decision-making, 
and the growth and research fundraising activities of 
groups more generally. While specialists’ concerns about 
misinformation may be more focused on web-based 
resources including online PCSGs, face-to-face groups 
may need to dissect out and better define and focus their 
role in decision and information support if they are to fur-
ther build specialist support and referral to their groups 
and programs.
Although this study is explorative, identified were 
some variations with respect to PCa specialist views 
about PCSGs. These findings as well as views that a lack 
of knowledge about PCSG might obscure PCSGs as a 
potential resource for men indicate that efforts are needed 
to raise awareness about PCSGs and its potential value in 
targeted and tailored communications to PCa specialists 
and men in the community. Engaging PCa survivors who 
have attended PCSGs to challenge assumptions and mis-
conceptions about PCSGs that are barriers to attendance 
is likely to be helpful. The positive experiences of other 
men can provide powerful examples to overcome fears 
among potential attendees. However, a parallel educa-
tional initiative to ensure that PCa specialists are well 
informed about PCSGs is also needed. The consideration 
of PCa specialists’ personal perspective is essential in the 
planning and implementation of this type of initiative.
The current study limitations include recognition that 
the reliability of PCa specialists to report what may or 
may not motivate patients to attend a PCSG is debatable. 
Moreover, PCa specialists’ perspectives about PCSGs are 
one among many potentially diverse health care provider 
views. Therefore, acknowledged also are the limits in 
terms of generalizability in describing the viewpoints of a 
small Canada-based sample of a PCa specialists. 
Nonetheless, these limitations provide important direc-
tion for future studies, which might include large interna-
tional multisite studies integrating qualitative interviews 
to more fully contextualize the findings offered in the 
current study.
While the PCSG sustainability issues raised by Oliffe 
et al. (2008) talked to the challenges connecting to non-
profit cancer agencies, the findings from the current study 
reveal the PCa specialists as allies with significant poten-
tial for advancing PCSGs, especially by raising aware-
ness with potential attendees. In this regard, formalizing 
collaborations might be mutually beneficial whereby a 
steady flow of new PCSG attendees can be mustered and 
the burden on clinical psychosocial oncology services 
further reduced.
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